4D pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| Q2 2020 | 137.5K | -6.86M | -4991.27% |
|---|
LBPSW Income Statement (Q2 2020 – Q2 2020)
| Q2 2020 | |
|---|---|
Revenue | |
Revenue | 137.5K |
Cost of revenue | 0 |
Gross profit | 137.5K |
Operating exp. | |
Research and development | 6.20M |
Selling and marketing | -10.5K |
Total operating expenses | 8.40M |
Operating income | -8.26M |
Other income (expenses), net | 418.5K |
Income before tax | -7.84M |
Income tax expense | -981.5K |
Net income | -6.86M |
Earnings per share | |
Basic EPS | -0.3 |
Diluted EPS | -0.3 |